Oncology player 4baseCare raises addl Rs.38-Cr to close Series B at Rs.128-Cr
Bengaluru-based precision oncology startup 4baseCare has raised an additional INR 38 crore to conclude its Series B funding round at INR 128 crore. The latest investment was led by growX Ventures, with participation from existing investors.Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare leverages genomics, bioinformatics, and AI to provide personalised oncology care. The company intends to use the capital to expand its genomics laboratory network across India, the Middle East, Southeast Asia, Latin America, and Central Asia.The funds will also be used to scale OncoTwin, the firm's AI-driven precision oncology platform, which provides clinicians with real-world, actionable clinical insights.
Between Mar-21 and Jan-26, 4baseCare had attracted about $ 19 M from Ashish Kacholia, Yali Capital, Infosys Innovation Fund, First In Ventures, Growx Ventures, Mount Judi Ventures, Season Two Ventures and others.For FY25, 4baseCare had reported about INR 3 Cr in Operating Income and about INR 2 Cr in Net Loss.
Want to receive such news items in your inbox? Click Here to sign up for a trial.